Variability in Hospital Costs of Adult Spinal Deformity Care.


Journal

Spine
ISSN: 1528-1159
Titre abrégé: Spine (Phila Pa 1976)
Pays: United States
ID NLM: 7610646

Informations de publication

Date de publication:
01 Sep 2020
Historique:
pubmed: 25 3 2020
medline: 17 12 2020
entrez: 25 3 2020
Statut: ppublish

Résumé

Retrospective, single-center analysis. To calculate the total clinical hospital cost of the Adult Spinal Deformity (ASD) care trajectory, to explain cost variability by patient and surgery characteristics, and to identify areas of process improvement opportunities. ASD is associated with a high financial and clinical burden on society. ASD care thus requires improved insights in costs and its drivers as a critical step toward the improvement of value, i.e., the ratio between delivered health outcome and associated costs. Patient characteristics and surgical variables were collected following ethical approval in a cohort of 139 ASD patients, treated between December, 2014 and January, 2018. Clinical hospital costs were calculated, including all care activities, from initial consultation to 1 year after initial surgery (excl. overhead) in a university hospital setting. Multiple linear regression analysis was performed to analyze the impact of patient and surgical characteristics on clinical costs. 75.5% of the total clinical hospital cost (&OV0556;27,865) was incurred during initial surgery with costs related to the operating theatre (80.3%), nursing units (11.9%), and intensive care (2.9%) being the largest contributors. 57.5% of the variation in total cost could be explained in order of importance by surgical invasiveness, age, coronary disease, single or multiple-staged surgery, and mobility status. Revision surgery, unplanned surgery due to complications, was found to increase average costs by 87.6% compared with elective surgeries (&OV0556; 44,907 (± &OV0556; 23,429) vs. &OV0556; 23,944 (± &OV0556; 7302)). This study identified opportunities for process improvement by calculating the total clinical hospital costs. In addition, it identified patient and treatment characteristics that predict 57.5% of cost variation, which could be taken into account when developing a payment system. Future research should include outcome data to assess variation in value. 4.

Sections du résumé

STUDY DESIGN METHODS
Retrospective, single-center analysis.
OBJECTIVE OBJECTIVE
To calculate the total clinical hospital cost of the Adult Spinal Deformity (ASD) care trajectory, to explain cost variability by patient and surgery characteristics, and to identify areas of process improvement opportunities.
SUMMARY OF BACKGROUND DATA BACKGROUND
ASD is associated with a high financial and clinical burden on society. ASD care thus requires improved insights in costs and its drivers as a critical step toward the improvement of value, i.e., the ratio between delivered health outcome and associated costs.
METHODS METHODS
Patient characteristics and surgical variables were collected following ethical approval in a cohort of 139 ASD patients, treated between December, 2014 and January, 2018. Clinical hospital costs were calculated, including all care activities, from initial consultation to 1 year after initial surgery (excl. overhead) in a university hospital setting. Multiple linear regression analysis was performed to analyze the impact of patient and surgical characteristics on clinical costs.
RESULTS RESULTS
75.5% of the total clinical hospital cost (&OV0556;27,865) was incurred during initial surgery with costs related to the operating theatre (80.3%), nursing units (11.9%), and intensive care (2.9%) being the largest contributors. 57.5% of the variation in total cost could be explained in order of importance by surgical invasiveness, age, coronary disease, single or multiple-staged surgery, and mobility status. Revision surgery, unplanned surgery due to complications, was found to increase average costs by 87.6% compared with elective surgeries (&OV0556; 44,907 (± &OV0556; 23,429) vs. &OV0556; 23,944 (± &OV0556; 7302)).
CONCLUSION CONCLUSIONS
This study identified opportunities for process improvement by calculating the total clinical hospital costs. In addition, it identified patient and treatment characteristics that predict 57.5% of cost variation, which could be taken into account when developing a payment system. Future research should include outcome data to assess variation in value.
LEVEL OF EVIDENCE METHODS
4.

Identifiants

pubmed: 32205695
doi: 10.1097/BRS.0000000000003497
pii: 00007632-202009010-00013
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1221-1228

Références

Porter ME. What is value in health care? N Engl J Med 2010; 363:2477–2481.
Pellisé F, Vila-Casademunt A, Ferrer M, et al. Impact on health related quality of life of adult spinal deformity (ASD) compared with other chronic conditions. Eur Spine J 2014; 24:3–11.
Kaplan RS, Porter ME. How to solve the cost crisis in Health care. Harv Bus Rev 2011; 89:46–52.
Kamerlink JR, Quirno M, Auerbach JD, et al. Hospital cost analysis of adolescent idiopathic scoliosis correction surgery in 125 consecutive cases. J Bone Joint Surg Am 2010; 92:1097–1104.
Sapountzi-krepia D, Psychogiou M, Peterson D, et al. Cost minimization in treatment of adult degenerative scoliosis. XXX 2006; 7:1–7.
Tosteson ANA, Skinner JS, Tosteson TD, et al. The cost effectiveness of surgical versus nonoperative treatment for lumbar disc herniation over two years: evidence from the Spine Patient Outcomes Research Trial (SPORT). Spine (Phila Pa 1976) 2008; 33:2108–2115.
Tosteson AN, Lurie JD, Tosteson TD, et al. Surgical treatment of spinal stenosis with and without degenerative spondylolisthesis: cost-effectiveness after 2 years. Ann Intern Med 2008; 149:845–853.
McCarthy IM, Hostin RA, O’Brien MF, et al. Analysis of the direct cost of surgery for four diagnostic categories of adult spinal deformity. Spine J 2013; 13:1843–1848.
Porter ME, Kaplan RS. How to pay for health care. Harv Bus Rev; 94.
VanLare JM, Conway PH. Value-based purchasing—national programs to move from volume to value. N Engl J Med 2012; 367:292–295.
Dietz N, Sharma M, Alhourani A, et al. Bundled payment models in spine surgery: current challenges and opportunities, a systematic review. World Neurosurg 2019; 123:177–183.
Sullivan R, Jarvis LD, O’Gara T, et al. Bundled payments in total joint arthroplasty and spine surgery. Curr Rev Musculoskelet Med 2017; 10:218–223.
Kahn EN, Ellimoottil C, Dupree JM, et al. Variation in payments for spine surgery episodes of care: implications for episode-based bundled payment. J Neurosurg Spine 2018; 29:214–219.
Segal DN, Wilson JM, Staley C, et al. The 5-item modified frailty index is predictive of 30-day postoperative complications in patients undergoing kyphoplasty vertebral augmentation. World Neurosurg 2018; 116:e225–e231.
Neuman BJ, Ailon T, Scheer JK, et al. Development and validation of a novel adult spinal deformity surgical invasiveness score: analysis of 464 patients. Neurosurgery 2018; 82:847–853.
Aebi M, Grob D. SSE Spine Tango: a European Spine Registry promoted by the Spine Society of Europe (SSE). Eur Spine J 2004; 13:661–662.
Santana A, Afonso P, Maria A, et al. Activity Based Costing and Time-Driven Activity Based Costing: Towards an Integrated Approach. In: ICOPEV - 2nd International Conference on Project Evaluation, Guimarães/PT 2014.
De Ryck D, Tambeur W, Vanden Boer G, et al. Analyse des Flux Financiers des hopitaux Généraux belges en Fonction du case-mix. J d’Economie Medicale 2008; 26:16–27.
Yeramaneni S, Ames CP, Bess S, et al. Center variation in episode-of-care costs for adult spinal deformity surgery: results from a prospective, multicenter database. Spine J 2018; 18:1829–1836.
Benahmed N, Briat G, Rondia K, Vlayen J. [Routine preoperative testing in adults undergoing elective non-cardiothoracic surgery]. Rev Med Brux 2018; 39:101–107.
Chotai S, Sivaganesan A, Parker SL, et al. Drivers of Variability in 90-day Cost for Primary Single-level Microdiscectomy Eric Stephens, MBA, CAP #. DOI: 10.1093/neuros/nyy209.

Auteurs

Karel Jacobs (K)

University Hospitals Leuven, Leuven, Belgium.
KU Leuven, Faculty of Medicine, LIGB (Leuven Institute for Health Policy), Leuven, Belgium.
KU Leuven, Faculty of Medicine, Institute for Orthopaedic Research and Training, Leuven, Belgium.
Vlerick Business School, Technology and Operations Management, Gent, Belgium.

Thibault Dewilde (T)

University Hospitals Leuven, Leuven, Belgium.
KU Leuven, Faculty of Medicine, Institute for Orthopaedic Research and Training, Leuven, Belgium.

Cindy Vandoren (C)

University Hospitals Leuven, Leuven, Belgium.

Brecht Cardoen (B)

Vlerick Business School, Technology and Operations Management, Gent, Belgium.
KU Leuven, Faculty of Economics and Business, Center for Operations Management, Leuven, Belgium.

Nancy Vansteenkiste (N)

University Hospitals Leuven, Leuven, Belgium.

Lennart Scheys (L)

University Hospitals Leuven, Leuven, Belgium.
KU Leuven, Faculty of Medicine, Institute for Orthopaedic Research and Training, Leuven, Belgium.

Filip Roodhooft (F)

KU Leuven, Faculty of Economics and Business, Research Centre Accountancy, Leuven, Belgium.
Vlerick Business School, Accounting and Finance, Gent, Belgium.

Lieven Moke (L)

University Hospitals Leuven, Leuven, Belgium.
KU Leuven, Faculty of Medicine, Institute for Orthopaedic Research and Training, Leuven, Belgium.

Katrien Kesteloot (K)

University Hospitals Leuven, Leuven, Belgium.
KU Leuven, Faculty of Medicine, LIGB (Leuven Institute for Health Policy), Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH